Na-908, Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Centre (Erasmus MC), Postbus 2040, 3000 CA, Rotterdam, Netherlands.
Hahn-Schickard, Georges-Koehler-Allee 103, 79110, Freiburg, Germany.
Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1015-1022. doi: 10.1007/s10096-019-03492-4. Epub 2019 Feb 2.
The emergence and spread of antimicrobial resistance is one of the major global issues currently threatening the health and wealth of nations, with effective guidelines and intervention strategies urgently required. Such guidelines and interventions should ideally be targeted at individuals, communities, and nations, requiring international coordination for maximum effect. In this respect, the European Joint Programming Initiative on Antimicrobial Resistance Transnational Working Group 'Antimicrobial Resistance - Rapid Diagnostic Tests' (JPIAMR AMR-RDT) is proposing to consider a 'mix-and-match' package for the implementation of point-of-care testing (PoCT), which is described in this publication. The working group was established with the remit of identifying barriers and solutions to the development and implementation of rapid infectious disease PoCT for combatting the global spread of antimicrobial resistance. It constitutes a multi-sectoral collaboration between medical, technological, and industrial opinion leaders involved in in vitro diagnostics development, medical microbiology, and clinical infectious diseases. The mix-and-match implementation package is designed to encourage the implementation of rapid infectious disease and antimicrobial resistance PoCT in transnational medical environments for use in the fight against increasing antimicrobial resistance.
抗菌药物耐药性的出现和传播是目前威胁各国人民健康和财富的主要全球问题之一,迫切需要制定有效的指导方针和干预策略。这些指导方针和干预措施理想情况下应针对个人、社区和国家,需要国际协调以达到最大效果。在这方面,抗菌药物耐药性-快速诊断检测欧洲联合规划倡议跨国工作组(JPIAMR AMR-RDT)提议考虑实施即时检测(PoCT)的“组合拳”方案,本出版物对此进行了描述。该工作组的任务是确定开发和实施快速传染病即时检测以应对全球抗菌药物耐药性传播的障碍和解决方案。它是一个由参与体外诊断开发、医学微生物学和临床传染病的医疗、技术和工业意见领袖组成的多部门合作组织。混合实施方案旨在鼓励在跨国医疗环境中实施快速传染病和抗菌药物耐药性即时检测,以对抗日益增加的抗菌药物耐药性。